Here are the top 7 drugmakers betting they can use antibodies to make effective coronavirus treatments much faster than a vaccine

An antibody therapeutic could land in the sweet spot of the hunt for a coronavirus treatment. Researchers think they could be relatively effective, and they could be available this fall, far sooner than a vaccine. They are likely to work much better against the virus than drugs being tested now in patients, since they are designed to fight the novel coronavirus. There are five major ongoing research efforts for an antibody treatment. The leading program, led by Eli Lilly, started human testing in June.  The leading efforts are from Lilly, Regeneron, Vir Biotechnology and GlaxoSmithKline, Amgen and Adaptive